Ampliphi Biosciences Corp (NYSE:APHB) was the target of a significant growth in short interest during the month of July. As of July 31st, there was short interest totalling 995,974 shares, a growth of 29.2% from the July 14th total of 770,981 shares. Based on an average daily volume of 1,063,625 shares, the short-interest ratio is currently 0.9 days. Approximately 11.6% of the shares of the company are sold short.
Shares of Ampliphi Biosciences Corp (NYSE APHB) traded down 6.341% on Wednesday, reaching $0.768. The company’s stock had a trading volume of 196,811 shares. Ampliphi Biosciences Corp has a 12-month low of $0.30 and a 12-month high of $38.25. The firm has a 50 day moving average price of $1.97 and a 200-day moving average price of $1.02. The stock’s market cap is $5.09 million.
WARNING: This news story was originally posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this news story on another publication, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this news story can be read at https://stocknewstimes.com/2017/08/09/short-interest-in-ampliphi-biosciences-corp-nyseaphb-increases-by-29-2.html.
About Ampliphi Biosciences Corp
AmpliPhi Biosciences Corporation is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products.
Receive News & Ratings for Ampliphi Biosciences Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences Corp and related companies with MarketBeat.com's FREE daily email newsletter.
